据报道，辉瑞（NYSE:PFE）和Moderna（NASDAQ:MRNA）正在与美国政府讨论建立一个可能的疫苗计划，旨在对抗H5N1病毒的传播，也被称为禽流感。美国卫生与公共服务部大流行准备助理部长Dawn O’Connell在周三收盘后与记者的电话会议上表示，该部门已经与两家疫苗开发商就生产基于mRNA的疫苗以预防禽流感进行了讨论[[根据巴伦周刊的说法]]。O’Connell表示，与疫苗制造商的谈判“正在进行中”，该机构“希望尽快完成并有所宣布”。她补充说，HHS一直在将政府的大批量库存中的480万剂禽流感疫苗转化为成品剂量。

Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are reportedly in talks with the U.S. government over setting up a possible vaccine program aimed at combatting the spread of the H5N1 virus, also known as avian flu.
U.S. Department of Health and Human Services Assistant Secretary of Pandemic Preparedness Dawn O’Connell said on a call with reporters after market close on Wednesday that the department has been in discussions with both vaccine developers about producing mRNA-based vaccines to protect against avian flu, 网页链接{according to Barron’s.}
O’Connell said negotiations with the vaccine makers are “ongoing” and that the agency was “hoping to wrap this up and have something to say very soon.” She added that HHS has been converting 4.8M doses of avian flu vaccine from the government’s bulk stockpile into finished doses.